A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Arformoterol
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Lafutidine
Lafutidine can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Metiamide
Metiamide can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Asenapine
Asenapine can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Rilpivirine.
Arformoterol
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Rilpivirine.
Arformoterol
Ilaprazole
Ilaprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Arformoterol
Troleandomycin
The serum concentration of Rilpivirine can be increased when it is combined with Troleandomycin.
Arformoterol
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Rilpivirine.
Arformoterol
Eliglustat
The metabolism of Eliglustat can be decreased when combined with Rilpivirine.
Alglucosidase alfa
Filgotinib
The serum concentration of Cholecystokinin can be increased when it is combined with Filgotinib.
Alglucosidase alfa
Revefenacin
Cholecystokinin may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Alglucosidase alfa
Rucaparib
The excretion of Cholecystokinin can be decreased when combined with Rucaparib.
Alglucosidase alfa
Selinexor
The excretion of Cholecystokinin can be decreased when combined with Selinexor.
Alglucosidase alfa
Baricitinib
The excretion of Cholecystokinin can be decreased when combined with Baricitinib.
Alglucosidase alfa
Ginsenoside Rb1
The excretion of Cholecystokinin can be decreased when combined with Ginsenoside Rb1.
Alglucosidase alfa
Ataluren
The excretion of Cholecystokinin can be decreased when combined with Ataluren.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3